This startup provides a compact, at-home device that uses microfluidic channels to isolate and concentrate healthy sperm from an ejaculated sample. This technology helps couples facing male infertility challenges improve their chances of conception by enhancing sperm quality for fertilization.
Funding
Funding not disclosed
Founders
Product
Problem
Many couples face challenges with male-factor infertility, which can significantly reduce their chances of conception. Traditional methods of sperm separation and preparation for fertilization can be stressful, inconvenient, and may not always yield the best results.
Solution
Fertilead offers two devices: Fertileasy, a home-use device, and Fertilitab, a clinic-based solution, both designed to improve sperm quality for fertilization. Fertileasy allows couples to enhance their chances of conceiving in the privacy of their home, avoiding the stress of traditional fertility treatments. Fertilitab provides fertility clinics with a state-of-the-art sperm separation method that leads to higher success rates for intrauterine insemination (IUI). Both devices utilize advanced microfluidic technology to isolate and concentrate healthy sperm from an ejaculated sample, increasing the likelihood of successful fertilization.
Target Audience
Fertilead targets couples experiencing male-factor infertility who are seeking to improve their chances of conception, as well as fertility clinics looking for advanced sperm separation solutions to improve IUI success rates.
Features
- Fertileasy: At-home sperm separation device designed for ease of use and privacy.
- Fertilitab: Clinic-based device offering advanced sperm separation for IUI procedures.
- Microfluidic channels: Technology used to isolate and concentrate healthy sperm.
- Improved sperm quality: Enhances sperm quality for a higher chance of successful fertilization.